News & Events

StageBio Welcomes Senior Pathologist, Dr. Tracey Papenfuss

It is with great honor that we introduce Dr. Tracey Papenfuss as a Senior Pathologist at StageBio. We are happy to have her on the team and look forward to all she will accomplish!

Join StageBio at the 2022 ARVO Annual Meeting & Expo

The StageBio team is looking forward to exhibiting and attending the ARVO Annual Meeting & Expo in Denver, Colorado. The ARVO conference will provide attendees access to new research, educational and professional development programming and networking opportunities for anyone working in the area of eye and vision research.

StageBio Welcomes Chief People and Business Integration Officer: Ellen Humphrey

StageBio StageBio is honored to introduce Ellen Humphrey as Chief People and Business Integration Officer to our team. We are happy to have her on board and look forward to all she will accomplish!

StageBio Welcomes Pathologist: Dr. Lauren Peiffer

StageBio is honored to introduce Dr. Lauren Peiffer as a Pathologist to our team. We are happy to have her on board and look forward to all she will accomplish!

StageBio Welcomes Senior Pathologist: Dr. Suresh Muthupalani

It is with great honor that we introduce Dr. Suresh Muthupalani as a Senior Pathologist at StageBio. We are happy to have him on the team and look forward to all he will accomplish!

Join StageBio at the 2022 SOT Annual Meeting & Expo

The StageBio team is looking forward to attending the 2022 Society of Toxicology’s Annual Meeting and ToxExpo in San Diego in March - and we hope to see you there!

StageBio Welcomes Lori Ball as Chief Executive Officer

StageBio Announces Lori Ball has been appointed as new CEO for StageBio, who brings a history of global leadership in the life sciences industry. Ms Ball will succeed Tom Galati, former CEO and Founder of StageBio, who will remain an integral part of the board of directors. Ms Ball will begin her role January 18, 2022.

3 Keys to Successful Pathology Endpoints in Inhalation Toxicology Studies

In a recent ACT 2021 Talking Tox webinar titled “Safety of E-Cigarette Products – A Toxicological Challenge,” I provided scientific guidance on pathology endpoints for inhalation studies. During my segment, I discussed the special planning necessary to optimize histopathology results when studying test articles dosed via the inhalation route (nose-only, head, or whole-body exposure).

StageBio Welcomes Senior Pathologist: Eric Lee

It is with great honor that we introduce Dr. Eric Lee as a Senior Pathologist at StageBio. We are happy to have him on the team and look forward to all he will accomplish!

Dr. Thomas Lemarchand to Present Findings on Novel Lambda Myeloma Antigen

StageBio’s very own Dr. Thomas Lemarchand will join his colleagues at the 63rd annual American Society of Hematology (ASH) meeting to present their findings on the newly designated Lambda Myeloma Antigen (LMA). During the presentation, which is titled, “A Novel B Cell Antigen Designated Lambda Myeloma Antigen (LMA) Has Been Identified Using Two Fully Human Monoclonal Antibodies (Mabs) That Bind to Similar Epitopes on Plasma Cells from Patients with Plasma Cell Dyscrasias,” Dr. Lemarchand and his team will detail the methods they used to detect the LMA, including flow cytometry on key cell lines and immunohisto-chemistry on normal and pathologic human frozen tissues and results, with what this could mean for myeloma treatment and understanding the pathogenesis.

Upcoming Events

ASGCT (American Society of Gene and Cell Therapy)

May 16-19, 2022, Walter E. Washington Convention Center, Washington, D.C.

Society of French Pathology Toxicology

May 19-20, Toulouse, France
Listen to our presentation by Dr. Serge Rousselle, CSO, on the scientific value of histopathological evaluation during the nonclinical safety assessment of medical devices

Learn more about StageBio’s COVID-19 response